Awaiting development: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Type 1 selected

Type

Guidance programme 1 selected

Guidance programme

Showing 1 to 2 of 2

TitleType
Doxecitine–doxribtimine for treating thymidine kinase 2 deficiency in people of any age who had symptoms before 13 years ID6484Highly specialised technology
OTL-101 for treating adenosine deaminase deficiency–severe combined immunodeficiency [ID1152]Highly specialised technology

Results per page

  1. 10
  2. 25
  3. 50
  4. All